Investor group presses U.S. drug companies on opioid controls

BOSTON (Reuters) - U.S. shareholder activists are addressing a soaring death toll from opioid drug abuse, asking companies that make and distribute the painkillers to review the risks their businesses could face from their role in the sector.

Investor group presses U.S. drug companies on opioid controls
Read More


Bagikan Berita Ini